Correlation Between Unilever PLC and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unilever PLC and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unilever PLC and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unilever PLC ADR and Entero Therapeutics,, you can compare the effects of market volatilities on Unilever PLC and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unilever PLC with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unilever PLC and Entero Therapeutics,.

Diversification Opportunities for Unilever PLC and Entero Therapeutics,

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Unilever and Entero is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Unilever PLC ADR and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Unilever PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unilever PLC ADR are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Unilever PLC i.e., Unilever PLC and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Unilever PLC and Entero Therapeutics,

Allowing for the 90-day total investment horizon Unilever PLC ADR is expected to generate 0.31 times more return on investment than Entero Therapeutics,. However, Unilever PLC ADR is 3.23 times less risky than Entero Therapeutics,. It trades about -0.1 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest  5,813  in Unilever PLC ADR on November 28, 2024 and sell it today you would lose (212.00) from holding Unilever PLC ADR or give up 3.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Unilever PLC ADR  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Unilever PLC ADR 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Unilever PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Entero Therapeutics, 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Unilever PLC and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unilever PLC and Entero Therapeutics,

The main advantage of trading using opposite Unilever PLC and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unilever PLC position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Unilever PLC ADR and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal